 Tanya Russell
Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Glands, Animal | 8 | 2011 | 129 | 1.340 |
Why?
| | Membrane Proteins | 8 | 2015 | 1167 | 0.860 |
Why?
| | Lipid Metabolism | 6 | 2011 | 509 | 0.690 |
Why?
| | Cytoplasm | 4 | 2011 | 274 | 0.640 |
Why?
| | Lactation | 6 | 2011 | 184 | 0.510 |
Why?
| | Phosphoproteins | 3 | 2015 | 338 | 0.480 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2015 | 56 | 0.470 |
Why?
| | Microfilament Proteins | 1 | 2015 | 131 | 0.450 |
Why?
| | Calcium-Binding Proteins | 1 | 2015 | 218 | 0.440 |
Why?
| | Milk | 3 | 2011 | 123 | 0.410 |
Why?
| | Trans-Activators | 1 | 2015 | 399 | 0.400 |
Why?
| | Epithelial Cells | 4 | 2015 | 1097 | 0.310 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1271 | 0.290 |
Why?
| | Perilipin-2 | 5 | 2011 | 41 | 0.270 |
Why?
| | Lipids | 2 | 2011 | 664 | 0.270 |
Why?
| | Peptides | 2 | 2008 | 981 | 0.230 |
Why?
| | Adenoviruses, Human | 1 | 2003 | 27 | 0.210 |
Why?
| | Breast Neoplasms | 1 | 2015 | 2243 | 0.200 |
Why?
| | Transduction, Genetic | 1 | 2003 | 126 | 0.200 |
Why?
| | Genetic Vectors | 1 | 2003 | 322 | 0.180 |
Why?
| | Flavonoids | 1 | 2020 | 83 | 0.170 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2020 | 132 | 0.170 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2020 | 87 | 0.160 |
Why?
| | Mice | 10 | 2015 | 17775 | 0.150 |
Why?
| | Cataract | 1 | 2020 | 213 | 0.140 |
Why?
| | Green Fluorescent Proteins | 2 | 2011 | 394 | 0.130 |
Why?
| | Epithelium | 2 | 2015 | 315 | 0.120 |
Why?
| | Quality of Health Care | 1 | 2020 | 626 | 0.120 |
Why?
| | Antigens, Differentiation | 1 | 2015 | 83 | 0.120 |
Why?
| | Animals | 11 | 2015 | 36915 | 0.110 |
Why?
| | Healthcare Disparities | 1 | 2020 | 632 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2020 | 1044 | 0.100 |
Why?
| | Caseins | 1 | 2011 | 20 | 0.090 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 664 | 0.090 |
Why?
| | Lipase | 1 | 2011 | 68 | 0.090 |
Why?
| | Perilipin-3 | 2 | 2008 | 4 | 0.090 |
Why?
| | Prolactin | 1 | 2011 | 100 | 0.090 |
Why?
| | Cell Membrane | 2 | 2011 | 751 | 0.080 |
Why?
| | Tight Junctions | 2 | 2007 | 77 | 0.080 |
Why?
| | Protein Folding | 1 | 2011 | 282 | 0.080 |
Why?
| | Phospholipids | 1 | 2011 | 223 | 0.080 |
Why?
| | Disease Progression | 1 | 2015 | 2744 | 0.070 |
Why?
| | Perilipin-1 | 1 | 2007 | 17 | 0.070 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 300 | 0.070 |
Why?
| | Carrier Proteins | 2 | 2008 | 770 | 0.060 |
Why?
| | Protein Kinase C | 1 | 2007 | 265 | 0.060 |
Why?
| | Female | 8 | 2015 | 72703 | 0.060 |
Why?
| | Protein Binding | 1 | 2011 | 2222 | 0.060 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2005 | 33 | 0.060 |
Why?
| | Mastitis | 1 | 2003 | 5 | 0.050 |
Why?
| | Adenoviridae Infections | 1 | 2003 | 17 | 0.050 |
Why?
| | Luminescent Proteins | 1 | 2003 | 178 | 0.050 |
Why?
| | Mice, Inbred C57BL | 1 | 2011 | 5766 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2007 | 1976 | 0.040 |
Why?
| | Apoptosis | 1 | 2007 | 2542 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2005 | 1769 | 0.030 |
Why?
| | Protein Structure, Tertiary | 2 | 2011 | 869 | 0.030 |
Why?
| | Pregnancy | 2 | 2011 | 6715 | 0.030 |
Why?
| | Humans | 5 | 2020 | 136899 | 0.030 |
Why?
| | Signal Transduction | 1 | 2007 | 5077 | 0.030 |
Why?
| | Prevalence | 1 | 2020 | 2709 | 0.030 |
Why?
| | Cell Line | 2 | 2008 | 2847 | 0.020 |
Why?
| | Bromocriptine | 1 | 2011 | 29 | 0.020 |
Why?
| | Hormone Antagonists | 1 | 2011 | 34 | 0.020 |
Why?
| | Milk Proteins | 1 | 2011 | 34 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2615 | 0.020 |
Why?
| | Pentose Phosphate Pathway | 1 | 2011 | 53 | 0.020 |
Why?
| | Growth | 1 | 2011 | 61 | 0.020 |
Why?
| | Glucose Transporter Type 1 | 1 | 2011 | 50 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2011 | 72 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 373 | 0.020 |
Why?
| | Glycolysis | 1 | 2011 | 319 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 974 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2011 | 844 | 0.020 |
Why?
| | Triglycerides | 1 | 2011 | 524 | 0.020 |
Why?
| | Oleic Acid | 1 | 2008 | 41 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2008 | 101 | 0.020 |
Why?
| | Pulmonary Alveoli | 1 | 2011 | 405 | 0.020 |
Why?
| | Fatty Acids | 1 | 2011 | 443 | 0.020 |
Why?
| | Occludin | 1 | 2007 | 12 | 0.020 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2007 | 16 | 0.020 |
Why?
| | Transforming Growth Factor beta3 | 1 | 2007 | 10 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2008 | 156 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2007 | 95 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2008 | 586 | 0.020 |
Why?
| | Thermodynamics | 1 | 2008 | 421 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 10313 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2011 | 854 | 0.020 |
Why?
| | Transfection | 1 | 2008 | 948 | 0.020 |
Why?
| | Protein Transport | 1 | 2007 | 443 | 0.020 |
Why?
| | Models, Molecular | 1 | 2011 | 1586 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2008 | 471 | 0.020 |
Why?
| | Cytoplasmic Vesicles | 1 | 2005 | 14 | 0.010 |
Why?
| | Claudins | 1 | 2005 | 25 | 0.010 |
Why?
| | United States | 1 | 2020 | 14595 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2007 | 596 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2007 | 2182 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1061 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2005 | 526 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2005 | 1739 | 0.010 |
Why?
| | Models, Biological | 1 | 2007 | 1774 | 0.010 |
Why?
| | Mutation | 1 | 2007 | 3948 | 0.010 |
Why?
|
|
Russell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|